# Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions

> **NCT04651959** · PHASE1 · UNKNOWN · sponsor: **Pharma Plant** · enrollment: 30 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** AVICOD 200 MG Film Tablet
- **DRUG:** AVIGAN 200 MG Film Tablets

## Key facts

- **NCT ID:** NCT04651959
- **Lead sponsor:** Pharma Plant
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-13
- **Primary completion:** 2020-11-18
- **Final completion:** 2020-12-20
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04651959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04651959, "Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04651959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*